Application Number: E.2.9 (medical devices) Fluororesin used: PTFE (CAS No. 9002-84-0) Product Overview: endoscope cable Fluororesin is used in cables for medical devices and cables of endoscope.

National PFAS Testing Strategy: Identification of Candidate Per- and Polyfluoroalkyl Substances (PFAS) for Testing October 2021 U.S.

KION GROUP Page 1 KION GROUP do LINDE Material Handling lberica S.A.U.

This information is an attachment to the restriction proposal for PFAS (appendix to Annex E.4) and compiles an The aim with this overview is to summarize relevant analytical methods for the analysis of PFASs in several matric Various sources of information have been investigated including recent peer-reviewed literature (2010-2022) and Information on analytics of relevant publications and standards were extracted in this excel sheet.

Proceedings of WTC2005 World Tribology Congress III September 12-16, 2005, Washington, D.C., USA WTC2005-63881 NANO-TRIBOLOGY OF A POLYTETRAFLUOROETHYLENE TRANSFER FILMS USING MOLECULAR DYNAMICS SIMULATION AND MICROTRIBOMETRY Inkook Jang*, Pamela L.

Vacuum Market Segmentation StlA I 15erMCCNIMICtfli loulgNol Inc Rough Vacuum Process Vacuum Industrial Vacuum Semiconductor Thin Film Deposition FPD Process Vacuum (non-Semiconductor) Solar inMsatrnuumfaecntutaretiorsn R&D Markets - Packaging (incept load) - Central Vacuum - Prnting and Paper Handling - Pick and Place Conveying - Moulding - Air sampling - Medical Markets -Chemical (Bulk.

3rd submission - Comment on Proposed Restriction of PFAS Conference of Fluoro-Chemical Product Japan (FCJ) (Regarding the requirement to provide information in paragraph 7) In paragraph 7 of the proposed restriction, the information requirement for derogated applications in paragraph 5 and 6 states that article manufacturers and importers need to provide information related to the identification of substances placed on the market.

HONEYWELL ADVANCED LIMITED Riverview House Harvey's quay Apartments Limerick V94R3DE Ireland 22 September 2023 PFAS REACH Annex XV Restriction Report 1ST Public Consultation (22 March - 25 September 2023) Exclusion or time-unlimited derogation of HFO-1234ze(E) propellants in technical aerosols applications from PFAS REACH restriction proposal.

CASE : MONITORING PFAS SCHOUWEMISSIES UIT DRAAITROMMELOVEN (DTO 2) VAN INDAVER NV: Samenvatting resultaten 2021-2023 Jelle Hofman, Patrick Berghmans, Gert Otten, Wouter Lefebvre, Aline Reis de Carvalho, Griet Jacobs Studie uitgevoerd deels in kader van de referentietaak LUCHT in opdracht van Departement Omgeving en deels in opdracht van Indaver 2N02V3/HEALTH/R/2995 augustus 2023 Inhoud INHOUD INLEIDING ...........................................................................................................................1 1.1.

Paris, 25.09.2023 English translation of the original French text below.

Integer.net September 25, 2023 To: European Chemicals Agency Re: PFAS Restriction Commentary Dear ECHA Consultation Committee, Integer manufactures complete medical devices as well as medical device components for many of the largest medical device companies in the world.

D-44149 Dortmund, Germany Tel.: Dit bericht kan informatie bevatten die niet voor u is bestemd.

Geschftsfhrer: Lorenz Grabow, Frithjof Sthamer USt.IDNr.: DE 118872866 Information ber die Verarbeitung Ihrer personenbezogenen Daten: Impressum

9.5.2003 EN Official Journal of the European Union I (Acts whose publication is obligatory) L 115/1 REGULATION (EC) No 782/2003 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 14 April 2003 on the prohibition of organotin compounds on ships THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION, Having regard to the Treaty establishing the European Community, and in particular Article 80(2) thereof, Having regard to the proposal from the Commission (1), Having regard to the opinion of the European Economic and Social Committee (2), Having consulted the Committee of the Regions, Acting in accordance with the procedure laid down in Article 251 of the Treaty (3), Whereas: (1) The Community is seriously concerned by the harmful environmental effects of organotin compounds used as anti-fouling systems on ships, and in particular of tributyltin (TBT) coatings. (2) An International Convention on the control of harmful anti-fouling systems on ships (AFS-Convention) was adopted on 5 October 2001 at a Diplomatic Conference (AFS-Conference) held under the aegis of the International Maritime Organisation (IMO) with the attendance of Member States of the Community. (3) The AFS-Convention is a framework convention allowing the prohibition of harmful anti-fouling systems used on ships in accordance with well-defined procedures and having due regard to the precautionary principle expressed in the Rio Declaration on Environment and Development. (4) The AFS-Convention, at this stage, only prohibits the application of organotin compounds on ships. (5) Fixed application dates have been included in the AFSConvention: 1 January 2003 for the prohibition of the application of organotin compounds on ships and 1 January 2008 for the elimination of the presence of organotin compounds on ships. (1) OJ C 262 E, 29.10.2002, p. 492. (2) Opinion delivered on 11 December 2002 (not yet published in the Official Journal). (3) Opinion of the European Parliament of 20 November 2002 (not yet published in the Official Journal) and Decision of the Council of 17 March 2003